Your browser doesn't support javascript.
loading
Genetic Variants of Complement Factor H Y402H (rs1061170), C2 R102G (rs2230199), and C3 E318D (rs9332739) and Response to Intravitreal Anti-VEGF Treatment in Patients with Exudative Age-Related Macular Degeneration.
Kubicka-Trzaska, Agnieszka; Zuber-Laskawiec, Katarzyna; Dziedzina, Sylwia; Sanak, Marek; Romanowska-Dixon, Bozena; Karska-Basta, Izabella.
Affiliation
  • Kubicka-Trzaska A; Clinic of Ophtalmology and Ocular Oncology, Department of Ophtalmology, Faculty of Medicine, Jagiellonian University Medical College, 31-501 Krakow, Poland.
  • Zuber-Laskawiec K; Clinic of Ophtalmology and Ocular Oncology, Department of Ophtalmology, Faculty of Medicine, Jagiellonian University Medical College, 31-501 Krakow, Poland.
  • Dziedzina S; Molecular Biology and Clinical Genetics Unit, Department of Internal Medicine, Faculty of Medicine, Jagiellonian University Medical College, 31-501 Krakow, Poland.
  • Sanak M; Molecular Biology and Clinical Genetics Unit, Department of Internal Medicine, Faculty of Medicine, Jagiellonian University Medical College, 31-501 Krakow, Poland.
  • Romanowska-Dixon B; Clinic of Ophtalmology and Ocular Oncology, Department of Ophtalmology, Faculty of Medicine, Jagiellonian University Medical College, 31-501 Krakow, Poland.
  • Karska-Basta I; Clinic of Ophtalmology and Ocular Oncology, Department of Ophtalmology, Faculty of Medicine, Jagiellonian University Medical College, 31-501 Krakow, Poland.
Medicina (Kaunas) ; 58(5)2022 May 13.
Article in En | MEDLINE | ID: mdl-35630075
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Complement Factor H / Bevacizumab / Macular Degeneration Limits: Humans Language: En Year: 2022 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Complement Factor H / Bevacizumab / Macular Degeneration Limits: Humans Language: En Year: 2022 Type: Article